Mercer Global Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75M | Buy |
|
|||||
|
2025
Q1 | $1.33M | Sell |
|
|||||
|
2024
Q4 | $1.65M | Buy |
|
|||||
|
2024
Q3 | $911K | Sell |
|
|||||
|
2024
Q2 | $1.12M | Buy |
|
|||||
|
2024
Q1 | $1.06M | Buy |
|
|||||
|
2023
Q4 | $697K | Buy |
|
|||||
|
2023
Q3 | $458K | Buy |
|
|||||
|
2023
Q2 | $318K | Buy |
|
|||||
|
2023
Q1 | $329K | Buy |
|
|||||
|
2022
Q4 | $369K | Buy |
|
|||||
|
2022
Q3 | $300K | Sell |
|
|||||
|
2022
Q2 | $328K | Buy |
|
|||||
|
2022
Q1 | $275K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $288K | Buy |
|
|||||
|
2020
Q4 | $229K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $225K | Buy |
|